← Eichor
Study identifier: NCT06724718 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

Condition: Postoperative Atrial Fibrillation · Thoracic Surgery · Smartwatches  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseNA
Planned participants302
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.

This description comes directly from the study's public registry record.

Talk to the study team

Pierre Huette, MD  ·  33322088371  ·  Huette.pierre@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre hospitalier AmiensAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06724718